San Francisco’s Invitae Tops IPO Targets With $102 Million Raise

Genetic testing firm Invitae Corp. bucked an IPO tide that has become choppy of late, raising more than expected in a $102 million offering.

The San Francisco company led by Randal Scott boosted the number of shares it offered and priced above its target range. It sold 6.35 million shares at $16. It had been expected to sell 5.35 million shares for between $13 and $15.

Hey, check out all the engineering jobs. Post your resume today!

MORE ON THIS TOPIC